Use of autologous conditioned platelet-rich plasma in the surgery of rhegmatogenous retinal ­detachment with large and multiple breaks, abruption from the dentate line

Abstract

Aim. To evaluate the effectiveness of surgical treatment of rhegmatogenous retinal detachment with large and multiple breaks, abruption from the dentate line with the use of 25, 27 Ga subtotal vitrectomy, pneumoretinopexy or silicone tamponade with blocking of retinal defects with the use of autologous conditioned platelet-rich plasma without endolaser coagulation around retinal defects.

Methods. The surgery included 25, 27 Ga vitrectomy, posterior hyaline membrane removal, pneumoretinopexy, instillation of 2–3 layers of autologous conditioned platelet-rich plasma deprived of leukocytes and containing 1.5–2 times more platelets than in whole blood into the area of retinal detachment, its break or along the edge of retinotomy till the retinal defect is totally covered. A total of 27 patients with visual acuity 0.03 to 0.9 were treated.

Results. In the early postoperative period 93% of patients had total retinal reattachment, in whim retinal detachment was blocked; 2 patients were reoperated. In the late postoperative period (1–12 months) 4 recurrent retinal detachments were registered, which also required reoperation. Visual acuity of the operated patients in the late postoperative period was 0.1–1.0.

Conclusion. 25, 27 Ga vitreoretinal surgery of rhegmatogenous retinal detachment with large retinal breaks, abruption from the dentate line, including retinotomy and retinal defects blockage with the use of autologous conditioned platelet-rich plasma without the use of endolaser coagulation is a method which allows achieving total reattachment of retina, better function of the operated eye in most cases.

Keywords

platelet-rich plasma / autologous conditioned plasma / rhegmatogenous retinal detachment with large and multiple breaks / retinal detachment with abruption from the dentate line / retinal detachment blockage without the use of endolaser coagulation

References

[1] Shkvorchenko D.O., Zakharov V.D., Kakunina S.A. et al. Current approaches to the surgical treatment of rhegmatogenous retinal detachment. Kataraktalʹnaya i refraktsionnaya khirurgiya. 2015; 15 (2): 4–10. (In Russ.)

[2] Шкворченко Д.О., Захаров В.Д., Какунина С.А. и др. Современные подходы к хирургическому лечению регматогенной отслойки сетчатки. Катарактальн. и рефракцион. хир. 2015; 15 (2): 4–10.

[3] Chalres S., Calzada J., Wood B. Vitreous Microsurgery. Lippincott Williams & Wilkins, Philadelphia, PA, 2007. 231 p. Russ. ed.: Chalres S., Calzada J., Wood B. Mikrokhirurgiya steklovidnogo tela i setchatki. Ed. by A.N. Samoylov. Moscow: MEDpress-inform. 2012; 400 p. (In Russ.)

[4] Чарльз С., Кальсада Х., Вуд Б. Микрохирургия стекловидного тела и сетчатки. Под ред. А.Н. Самойлова. М.: МЕДпресс-информ. 2012; 400 с.

[5] Lyskin P.V., Zakharov V.D., Zgoba M.I. Effect of endolasercoagulation on postoperative period in patients with retinal detachment. Sovremennye tekhnologii v oftalʹmologii. 2017; (1): 173–176. (In Russ.)

[6] Лыскин П.В., Захаров В.Д., Згоба М.И. Влияние эндолазеркоагуляции на послеоперационный период у пациентов с отслойкой сетчатки. Соврем. технол. в офтальмол. 2017; (1): 173–176.

[7] Pashtaev N.P., Arsyutov D.G. The use of medical glue in the treatment of progressive myopia and retinal detachment. Oftalʹmokhirurgiya. 2009; (3): 16–20. (In Russ.)

[8] Паштаев Н.П., Арсютов Д.Г. Использование медицинских клеев в хирургии прогрессирующей миопии и отслойки сетчатки. Офтальмохирургия. 2009; (3): ­16–20.

[9] Achkasov E.E., Bezuglov E.N., Ulʹyanov A.A. et al. Application platelet-rich plasma in clinical practice. Biomeditsina. 2013; (4): 46–59. (In Russ.)

[10] Ачкасов Е.Е., Безуглов Э.Н., Ульянов А.А. и др. Применение аутоплазмы, обогащённой тромбоцитами, в клинической практике. Биомедицина. 2013; (4): 46–59.

[11] Nikolidakis D., Jansen J. The biology of platelet-rich plasma and its application in oral surgery: Literature review. Tissue Engineering; Part B. 2008; 14 (3): 249–258. DOI: 10.1089/ten.teb.2008.0062.

[12] Arsyutov D.G. Use of platelet-rich plasma in the surgery of rhegmatogenous retinal detachment. Sovremennye tekhnologii v oftalʹmologii. 2018; (1): 32–34. (In Russ.)

[13] Арсютов Д.Г. Использование обогащённой тромбоцитами плазмы в хирургии регматогенной отслойки сетчатки. Соврем. технол. в офтальмол. 2018; (1): ­32–34.

[14] Shkvorchenko D.O., Zakharov V.D., Shpak A.A. et al. Our experience of the use of platelet-rich plasma in the surgery of macular tears. Sovremennye tekhnologii v oftalʹmologii. 2016; (1): 245–246. (In Russ.)

[15] Шкворченко Д.О., Захаров В.Д., Шпак А.А. и др. Наш опыт применения богатой тромбоцитами плазмы крови в хирургии макулярных разрывов. Соврем. технол. в офтальмол. 2016; (1): 245–246.

[16] Zhomova M.V. Use of autologous serum in knee osteoarthritis. PhD thesis.Yaroslavlʹ: 2011; 27 р. (In Russ.)

[17] Жомова М.В. Применение аутологичной сыворотки при остеоартрозе коленных суставов. Автореф. дисс. кандидата мед. наук. Ярославль: 2011; 27 с.

RIGHTS & PERMISSIONS

Arsyutov D.G.